Setareh van Driel Shamsili
Keine laufenden Positionen mehr
Profil
Setareh van Driel Shamsili served as the Chief Medical Officer & Senior Vice President at Merus NV from 2012 to 2016.
He also worked as the Global Medical Leader-Oncology at Astellas Pharma Global Development, Inc. He later became the Chief Medical Officer at Ryvu Therapeutics SA from 2019 to 2022.
Dr. van Driel Shamsili holds a doctorate degree from Erasmus University Rotterdam and a graduate degree from Tehran University of Medical Sciences.
Ehemalige bekannte Positionen von Setareh van Driel Shamsili
| Unternehmen | Position | Ende |
|---|---|---|
| RYVU THERAPEUTICS S.A. | Chief Tech/Sci/R&D Officer | 01.02.2022 |
| MERUS N.V. | Chief Tech/Sci/R&D Officer | 01.01.2016 |
Astellas Pharma Global Development, Inc.
 Astellas Pharma Global Development, Inc. Pharmaceuticals: MajorHealth Technology Astellas Pharma Global Development, Inc. provides business services. The company is headquartered in Deerfield, IL. | Corporate Officer/Principal | - |
Ausbildung von Setareh van Driel Shamsili
| Erasmus University Rotterdam | Doctorate Degree |
| Tehran University of Medical Sciences | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| MERUS N.V. | Health Technology |
| RYVU THERAPEUTICS S.A. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Astellas Pharma Global Development, Inc.
Astellas Pharma Global Development, Inc. Pharmaceuticals: MajorHealth Technology Astellas Pharma Global Development, Inc. provides business services. The company is headquartered in Deerfield, IL. | Health Technology |
